This Truist Financial Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
This Truist Financial Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
This Truist Financial Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
10 Health Care Stocks With Whale Alerts In Today’s Session
EXCLUSIVE: Market Expert Jay Woods Picks Top 2 Magnificent Seven Stocks For Rest of 2026, 2027
Shares of software companies are trading higher after a Guggenheim report suggested that AI concerns may be overblown.
Nvidia, Tesla, Caterpillar: ETFs Most Exposed to Michael Burry's New Shorts
Walmart Shares Slip Amid Sales Slowdown Concerns
Sony Ends Physical Discs For Games By 2028, Why GameStop Needs eBay Or Another Growth Plan
'Apple Seeks to Buy Chinese-Made Memory Chips With Lobbying Push'- Bloomberg
'Softbank In Talks With Lenders On Securing $10B Margin Loan Backed By OpenAI Stake And Repayment Guarantee; Previous Softbank Efforts To Secure Loan Against Its OpenAI Stake Had S…
'Apple Readies New iPad Pro, Redesigned Entry MacBook Pro for 2027'- Bloomberg
SABA ILAC SANAYIVE has secured FDA approval for ANDA 217934, a milestone that is expected to expand the manufacturer's commercial portfolio and provide a solid foundation for futur…
MANKIND PHARMA received FDA approval for its ANDA 220874 on July 1, 2026, according to a notice issued by the regulatory body. This clearance is expected to deliver a significant c…
Macleods Pharmaceuticals Limited and Hikma Pharmaceuticals received FDA approval for their generic chlorthalidone ANDA on July 1, 2026, which is expected to assert significant mark…
InnSuites Hospitality Trust received a NYSE American notice for non-compliance with continued listing standards due to equity deficits and losses, pledging a plan by July 24 to reg…
The FDA has approved TREGZI, the first regulatory T cell-based immunotherapy, to improve chronic GVHD-free survival in adult blood cancer patients undergoing stem cell transplant.
An investor agreed to forego redeeming shares for founder shares to support a proposed charter amendment. This transaction secures voting support for Plum Acquisition Corp IV regar…
The company entered an indenture for the issuance of $130 million in 0% exchangeable senior notes due 2031. This offer demonstrates the company's access to capital markets despite …
Aptose Biosciences announced the closing of the acquisition by Hanmi Pharmaceutical, delisting shares on July 3. Shareholders received C$2.41 per share, representing a 28% premium …
Old Republic announced the conversion of Everett Cash Mutual Insurance Co. to a stock company and finalized its purchase of the ECM Group. Shareholders invested approximately $25 m…
News Corp filed a notification for a repurchase program of up to US$1 billion for its Class A common stock. This initiative signifies a capital return strategy to increase sharehol…